Weight Watchers enters obesity drug space. What it means for the stock
WW International is steering hard in a new direction, hoping to turn the growing interest in obesity medications to its advantage. On paper, the new strategy could be the answer…
This startup can grab a piece of the lucrative obesity drug market
It’s been hard to miss the buzz around a new class of obesity medications , but one big drawback to these therapies is that they require a weekly injection. Enter…
Biden proposal to cap all insulin prices at $35 a month has little chance of passing Congress
President Joe Biden delivers the State of the Union address to a joint session of Congress on Feb. 7, 2023 Pool | Getty Images President Joe Biden used the bully…
Eli Lilly investors spooked by weak Mounjaro sales, but real demand is untapped
The demand is there, but so are the hurdles. Eli Lilly investors got a reality check on Thursday, as the stock tumbled more than 6%. Hopes have been running high…
New GLP-1 weight loss drugs are about to ship to more American homes
Using GLP-1s drug injections for weight loss has become one of the latest ways some big names in the market are shedding extra pounds. Elon Musk recently tweeted about how…
People with diabetes struggle to find Ozempic as it soars in popularity as a weight loss aid
Tammie Rachell Largent-Phillips, 52, has Type 2 diabetes. For the past two years, she’s managed the condition using a drug called Ozempic, which helps people with diabetes keep blood sugar…
Obesity drugs like Wegovy winning support among doctors and insurers
Drugs that treat obesity and overweight are improving their efficacy. They are also increasingly being prescribed by doctors and covered by insurers – a win for patients and for investors.…
Eli Lilly 2022 gains grow to 20% as it lays out plan for obesity drug, tirzepatide
Eli Lilly’s drug tirzepatide has been granted “fast track” status by the Food and Drug Administration, which means it could win approval to be prescribed as an obesity treatment as…